Posted by AGORACOM-JC
at 7:49 AM on Thursday, January 7th, 2021
Announced today that it has entered into a binding Letter of Intent to acquire 100% of Concierge Medical Consultant Inc., an arm’s length private telehealth and medical concierge services company
Company believes that in the current pandemic environment that there is a likely increase in mental health issues in society attributed to periods of extended isolation and related the disruption of social interaction.
Accordingly, management of the Company feel that there is a significant need in the market place for provide personal health solutions and the Company recognizes telehealth and concierge medical service as a part of solution to this growing problem.
Toronto, Ontario–(January 7, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce today that it has entered into a binding Letter of Intent (the “LOI“) to acquire 100% of Concierge Medical Consultant Inc. (“Concierge“), an arm’s length private telehealth and medical concierge services company, incorporated under the laws of British Columbia (the “Transaction”).
Subject to the completion of satisfactory due diligence by both Datametrex and Concierge, under the terms and conditions of the LOI, Datametrex and Concierge will enter into a Definitive Agreement (the “Definitive Agreement“) on or about January 20, 2021.
The Company believes that in the current pandemic environment that there is a likely increase in mental health issues in society attributed to periods of extended isolation and related the disruption of social interaction. Accordingly, management of the Company feel that there is a significant need in the market place for provide personal health solutions and the Company recognizes telehealth and concierge medical service as a part of solution to this growing problem.
“We strongly believe that there is a growing need for remote health and wellness solutions as a result of the pandemic. The lockdowns and the isolation that Canadians have endured this past year have only increased the need for mental and physical health solutions. By providing Telehealth solutions we are able to keep people out of the already overwhelmed hospital infrastructure while at the same time providing Canadians with professional advice and care that they need and deserve.”, said Andrew Ryu, the Company’s Chairman.
Posted by AGORACOM-JC
at 7:44 AM on Thursday, January 7th, 2021
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas,TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and colleges
Announced the successful launch of our KAI Saliva PCR Test with our initial soft launch of 5,000 units sold out and the order of 25,000 additional units with a sales value of approximately $5,500,000.
Initial and overwhelming demand for KAI Saliva stemmed from our existing customers in film & television productions, the commercial sector, and concierge testing supported by Sun Valley Health in Arizona.
Given the early and significant success of KAI Saliva since its launch on December 15, 2020, Empower is extremely confident in the continued success of KAI Saliva with both existing and expanded commercial customers in this next run.
VANCOUVER, BC / January 7, 2021 / EMPOWER CLINICS INC. (CBDT:CSE)(8EC:Frankfurt)(EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce the successful launch of our KAI Saliva PCR Test (“KAI Saliva”) with our initial soft launch of 5,000 units sold out and the order of 25,000 additional units with a sales value of approximately $5,500,000.
INITIAL DEMAND FOR FIRST RUN KAI SALIVA CAME FROM EXISTING COMMERCIAL CUSTOMERS, INCLUDING FILM & TELEVISION PRODUCTIONS. DIRECT TO CONSUMER CHANNEL LAUNCH IMMINENT
Initial and overwhelming demand for KAI Saliva stemmed from our existing customers in film & television productions, the commercial sector, and concierge testing supported by Sun Valley Health in Arizona. Given the early and significant success of KAI Saliva since its launch on December 15, 2020, Empower is extremely confident in the continued success of KAI Saliva with both existing and expanded commercial customers in this next run.
Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, Kai Medical Laboratory, small cap stocks, tsx Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF KAI Medical Laboratory Sells Out First 5,000 Units Of FDA EUA Approved Saliva #COVID-19 Test Kits. Issues Order For Next 25,000 KAI Saliva PCR Test Kits With Sales Value Of $5.5M. Discussions With Major Airlines Underway $WELL.ca $DOC.ca $DOCRF $VMD.ca
Posted by AGORACOM-JC
at 7:40 AM on Thursday, January 7th, 2021
Announced that the Company has appointed Danny M Spataro as Sr. Director of Sales, Sports, and Entertainment, effective January 11th.
Danny joins Loop Insights with over 15 years of sales experience in collegiate athletics, professional sports, and SaaS. Danny spent 11 years with Learfield IMG College, highlighted by sales leadership roles serving Texas A&M, Arizona, Penn State, Northwestern, and Harvard. Danny left Learfield IMG College to work with Fenway Sports Management, the parent company of the Boston Red Sox, Liverpool Football, and New England Sports Network.
VANCOUVER, British Columbia, Jan. 07, 2021 — Loop Insights Inc. (MTRX:TSXV OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue management for the brick and mortar space, is pleased to announce that the Company has appointed Danny M Spataro as Sr. Director of Sales, Sports, and Entertainment, effective January 11th.
Spataro Brings Over 15 Years Of Sales and Marketing Experience to Loop Insights, Including Roles In Collegiate and Professional Sports
Danny joins Loop Insights with over 15 years of sales experience in collegiate athletics, professional sports, and SaaS. Danny spent 11 years with Learfield IMG College, highlighted by sales leadership roles serving Texas A&M, Arizona, Penn State, Northwestern, and Harvard. Danny left Learfield IMG College to work with Fenway Sports Management, the parent company of the Boston Red Sox, Liverpool Football, and New England Sports Network. After Fenway, Danny spent time at New Hampshire Motor Speedway (SMI), part of the NASCAR circuit. Spataro’s last three years have been highlighted by successful tenures at technology giant Oracle Corporation and most recently SSB. Danny brings a wealth of sales and technology experience to Loop Insights that will greatly benefit the team moving forward.
Posted by AGORACOM-JC
at 7:35 AM on Thursday, January 7th, 2021
Announces record THC test results achieved via data driven process improvements at wholly owned subsidiary Lyfted Farms.
Recent testing by a State certified, third party laboratory confirmed total THC to be 31.3% and total cannabinoids at 41.43% for the Lyfted Farms’ Garlic NoodlesTM cannabis flower, both are record levels for Lyfted Farms indoor cultivation team.
Notably, total flower yield also increased by 17%.
Vancouver, British Columbia–(January 7, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces record THC test results achieved via data driven process improvements at wholly owned subsidiary Lyfted Farms.
Recent testing by a State certified, third party laboratory confirmed total THC to be 31.3% and total cannabinoids at 41.43% for the Lyfted Farms’ Garlic NoodlesTM cannabis flower, both are record levels for Lyfted Farms indoor cultivation team. Notably, total flower yield also increased by 17%.
Systematic, data driven process enhancements to multiple facets of the genetics-to-harvest cycle have resulted in superior test results for total THC, total cannabinoids, and yield metrics.
Posted by AGORACOM-JC
at 7:08 PM on Wednesday, January 6th, 2021
The world of small cap technology is getting more exciting everyday. The AGORACOM thesis for this decade is that more wealth will be created from cheaper and more powerful tech than the last 2 decades combined. Said another way, the little guy has never been in a better position to compete and even beat the big guys.
Today’s press release between KABN North America (KABN:CSE) and XTM Inc. (PAID:CSE) is a prime example. Powered by XTM, KABN is launching its prepaid Visa Card and digital banking platform to support its challenger bank initiatives in North American.
What is a “challenger bank”?. Glad you asked. Here is the best explanation we found
“In the age of business disruptors, it is no surprise that we are seeing a shakeup within the financial services sector now in the form of challenger banks. The purpose of these challenger banks is to compete with the long-established big banks and give consumers more options in the fintech world. Popularly considered to be small-medium retail operations set up with the purpose of competing against other, larger and more established banking institutions, challenger banks are heralding an exciting era in finance for customers.”
KABN has no intention of becoming a bank but it does want to provide their Liquid Avatar customers with online banking solutions important to them. With all of the necessary approvals and partnership agreements in place, KABN North America will begin rolling out the program in Canada throughout the first quarter of 2021 and has plans to continue its card program rollout to the U.S. and other geographic regions
What is Liquid Avatar? Glad you asked. To understand it you first have to understand and remember that Facebook and other tech giants showed the world that sharing our private data and profiting from it is a major issue. It became such a major issue that sweeping laws have been enacted in Europe (GDPR) and the United States (CCPA) that not only puts a stop to these practices but also demand that individuals are given the opportunity to take control of their digital identities – and even profit from them.
The term is often referred to as “Self Sovereign Identity (SSI)” and though it sounds kind of complicated, it actually sounds like music to the ears of investors that want to learn more about this massive global trend.
KABN is the small cap company that is leaps and bounds ahead of any other small cap company in this space. Their technology delivering your online identity is damn cool (check out www.LiquidAvatar.com) and their global recognition is even better given their recent addition to the Trust Over IP Foundation as a Steering Member, joining the likes of IBM, Mastercard, Accenture and other global giants that are forming an ecosystem around SSI
This is a global paradigm shift that you DO NOT want to miss because it is happening right now and KABN is the leading small cap company for investors to gain exposure. Why? Because they are turning the problem of data privacy into a profit for people like you and me.
Posted by AGORACOM
at 4:14 PM on Wednesday, January 6th, 2021
Mechanized excavations of the overburden exposed the bedrock before it plunges deeper into the historical placer gold channel.
Geological mapping and structural study to the east and west of Rang St-Gustave road will provide requisite data to optimize the drill program
Montreal, Quebec–(Newsfile Corp. – January 6, 2021) – Beauce Gold Fields(Champs D’Or en Beauce) (TSXV: BGF) (“BGF”), is pleased to announce that it has completed its trenching and rock outcrop exploration program in the Rang St-Gustave sector of the gold property located in St-Simon-Les-Mines in the Beauce region of southern Quebec.
Patrick Levasseur, President and CEO of Beauce Gold Fields said, “The Rang St-Gustave area was the site of the only major placer mining and dredging operation in eastern North America. In this same sector, the company discovered a major geological fault which could explain, in part, the gold bearing structures.” Mr. Levasseur added: “The data provided by the survey and sampling of the trenches will better guide our future rock drilling program to uncover the source of the gold placers.”
Figure 1. Location of the trenches made in the St-Gustave sector and trajectory of the Yuba dredge used during the exploitation of the gold placer.
Posted by AGORACOM-JC
at 12:01 PM on Wednesday, January 6th, 2021
Peter Pascali , President & CEO, PyroGenesis Canada Inc. (TSX: PYR), shares his company’s story in an interview with TMX Group.
The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html .
Posted by AGORACOM-JC
at 9:40 AM on Wednesday, January 6th, 2021
Company issued 3,555,556 Units at a price of $0.225 per Unit for gross proceeds of $800,000. Each Unit is comprised of one common share (each a “Common Share”) and one Common Share purchase warrant (a “Warrant”).
Each Warrant entitles the holder thereof to purchase one Common Share (each, a “Warrant Share”) at a price of $0.30 per Warrant Share for a period of 24 months following the closing of the Private Placement.
TORONTO, Jan. 06, 2021 — Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, is pleased to announce that it has closed a non-brokered private placement (the “Private Placement”) of units (the “Units”) with a group of strategic investors. The Company issued 3,555,556 Units at a price of $0.225 per Unit for gross proceeds of $800,000. Each Unit is comprised of one common share (each a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share (each, a “Warrant Share”) at a price of $0.30 per Warrant Share for a period of 24 months following the closing of the Private Placement. In connection with the Private Placement, the Company will pay a finder’s fee equal to 7% of the gross proceeds of the Private Placement.
As at September 30, 2020, the Company had a cash position of $41,017. The Company subsequently completed private placements on October 6, 2020, November 10, 2020 and November 30, 2020 for aggregate gross proceeds of $450,000. Combined with the current Private Placement, the Company has substantially strengthened its balance sheet and improved its financial flexibility. The proceeds from the Private Placement will be used to accelerate the Company’s product strategy and hire development personnel.
Posted by AGORACOM-JC
at 9:33 AM on Wednesday, January 6th, 2021
Announced the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
Los Angeles, CA, Jan. 06, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.
Posted by AGORACOM-JC
at 8:29 AM on Wednesday, January 6th, 2021
Avicanna Advances Pharmaceutical Epilepsy Program With Collaboration With the University Health Network and GMP Manufacturing of its First Pharmaceutical Preparation
The multi-level cannabinoid-based collaboration with leading epilepsy researcher Dr. Peter Carlen at the world-renowned Krembil Research Institute at UHN is also supported by a Mitacs Accelerate program grant.
UHN scientists will be analyzing Avicanna’s RHO Phyto™ cannabinoid-based products for their efficacy on comorbidities and seizure control in addition to identifying optimized cannabinoid and non-cannabinoid ratios for future drug development.
First fully GMP and ICH compliant manufacturing of Avicanna’s proprietary pharmaceutical preparation to treat epilepsy has been completed by Altea Farmaceutica S.A. in preparation for registration and commercialization in South America.
TORONTO, Jan. 06, 2021 — Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that the Company has entered into a master services agreement (the “ Master Services Agreement ” ) with the University Health Network (“ UHN ”) for projects to be performed by Dr. Peter Carlen as the principal investigator related to epilepsy. Additionally, the company has completed the technical transfer and first pharmaceutical pilot production of its epilepsy drug candidate at Altea Farmaceutica S.A. (“ Altea ”) in Bogota, Colombia, a major step required for the final preparation for its registration and commercialization in South America.
